Health consciousness among Indians is great news for Probiotics Market

New Delhi: The probiotics market is one of the highest growth potential markets in the country. Due to growing health consciousness among the people, change in diet, increasing number of patients with Type II Diabetes, and lifestyle-related disorders like obesity, probiotics have become popular among the masses as an organic solution to the problem. This has created quite a significant supply-demand gap and has birthed new opportunities for entrepreneurs who want to enter in this field.

According to the research conducted by the World Health Organization (WHO), nearly 31% of all deaths worldwide are caused by heart-related diseases. Alarmingly, 82% of these premature deaths happened in low and middle-income countries like India. This has made people adopt a more health-centric lifestyle and has increased the demand for probiotics in the market. Moreover, the demand for probiotics isn’t just limited to humans. Many farmers practising animal husbandry are opting for probiotics food products and supplements for their cattle as well.

Although, there are many foreign and domestic brands that are already enjoying a trailblazing performance in the lucrative probiotic market of India, last year, 87 startups and entrepreneurs were funded by the Government. Earlier, the market had been divided into three major segments: Probiotic functional food and beverages; Probiotic drugs and dietary supplements; and Probiotic animal feed. Lately, beauty & cosmetics also becomes a prominent category in this realm.

Risers Accelerator, a conglomerate of 35 successful young entrepreneurs based out of Delhi has always aimed at empowering startups with good market potential. Even though the probiotic market is relatively new in India, it is expanding very quickly and those who stick their feet into it now, will have a very lucrative future.

“Given the increasing healthcare cost, rising lifestyle disorders and a generation that is health conscious, complemented with the increasing purchasing power of the Indian customer and rapid urbanization, the probiotic market in India is going to really bloom in the coming few years. This health-centric lifestyle is a boon for probiotic startups.

At Risers Accelerator, we have always invested in startups that have shown great market potential, and startups in the field of probiotics have a real opportunity now to make their impact on the market. We intend to empower such startups to attain their goals and contribute in raising the country’s economy,” said Mr. Pravin Khandelwal, Director, Leadership and Motivation at Risers Accelerator.

Related Posts

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy